IL151168A0 - Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds - Google Patents

Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds

Info

Publication number
IL151168A0
IL151168A0 IL15116801A IL15116801A IL151168A0 IL 151168 A0 IL151168 A0 IL 151168A0 IL 15116801 A IL15116801 A IL 15116801A IL 15116801 A IL15116801 A IL 15116801A IL 151168 A0 IL151168 A0 IL 151168A0
Authority
IL
Israel
Prior art keywords
phthalascidin
ecteinascidin
compounds
producing
production
Prior art date
Application number
IL15116801A
Other languages
English (en)
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of IL151168A0 publication Critical patent/IL151168A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15116801A 2000-02-11 2001-02-09 Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds IL151168A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18179500P 2000-02-11 2000-02-11
PCT/US2001/004376 WO2001058905A1 (en) 2000-02-11 2001-02-09 Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds

Publications (1)

Publication Number Publication Date
IL151168A0 true IL151168A0 (en) 2003-04-10

Family

ID=22665840

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15116801A IL151168A0 (en) 2000-02-11 2001-02-09 Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds
IL151168A IL151168A (en) 2000-02-11 2002-08-09 Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151168A IL151168A (en) 2000-02-11 2002-08-09 Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds

Country Status (22)

Country Link
EP (1) EP1255759B1 (cs)
JP (1) JP5102925B2 (cs)
KR (1) KR100768331B1 (cs)
CN (1) CN1230437C (cs)
AT (1) ATE368670T1 (cs)
AU (2) AU2001238135B2 (cs)
BR (1) BRPI0108279B1 (cs)
CA (1) CA2400614C (cs)
CY (1) CY1107769T1 (cs)
CZ (1) CZ300326B6 (cs)
DE (1) DE60129669T2 (cs)
DK (1) DK1255759T3 (cs)
ES (1) ES2290114T3 (cs)
HU (1) HU229511B1 (cs)
IL (2) IL151168A0 (cs)
MX (1) MXPA02007767A (cs)
NO (1) NO328648B1 (cs)
NZ (1) NZ520635A (cs)
PL (1) PL209762B1 (cs)
PT (1) PT1255759E (cs)
RU (1) RU2267492C2 (cs)
WO (1) WO2001058905A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2576569B1 (en) 2010-05-25 2015-01-14 Pharma Mar S.A. Synthetic process for the manufacture of ecteinascidin compounds and intermediates
CN108101934B (zh) * 2016-11-24 2022-02-08 江苏恒瑞医药股份有限公司 用于制备曲贝替定的方法及其中间体
CN110092802B (zh) * 2019-06-21 2022-01-07 爱斯特(成都)生物制药股份有限公司 一种制备曲贝替定中间体的方法
CN112745327B (zh) * 2019-10-30 2023-08-25 南通诺泰生物医药技术有限公司 一种曲贝替定中间体化合物的制备方法
CN114621245A (zh) * 2020-12-11 2022-06-14 江苏恒瑞医药股份有限公司 一种曲贝替定中间体的晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743

Also Published As

Publication number Publication date
CA2400614C (en) 2010-10-19
WO2001058905A1 (en) 2001-08-16
EP1255759A4 (en) 2004-11-03
IL151168A (en) 2008-11-03
HUP0204221A3 (en) 2004-04-28
BRPI0108279B1 (pt) 2016-04-26
NO20023769L (no) 2002-10-10
CN1230437C (zh) 2005-12-07
KR20020086517A (ko) 2002-11-18
NO328648B1 (no) 2010-04-19
EP1255759B1 (en) 2007-08-01
HU229511B1 (en) 2014-01-28
ATE368670T1 (de) 2007-08-15
JP2003522190A (ja) 2003-07-22
CZ20022683A3 (cs) 2003-01-15
PL209762B1 (pl) 2011-10-31
MXPA02007767A (es) 2002-10-23
PL356392A1 (en) 2004-06-28
RU2267492C2 (ru) 2006-01-10
RU2002124134A (ru) 2004-01-10
AU3813501A (en) 2001-08-20
AU2001238135B2 (en) 2006-08-17
ES2290114T3 (es) 2008-02-16
BR0108279A (pt) 2002-11-05
EP1255759A1 (en) 2002-11-13
CY1107769T1 (el) 2013-04-18
DE60129669D1 (de) 2007-09-13
PT1255759E (pt) 2007-10-02
HUP0204221A2 (hu) 2003-04-28
CA2400614A1 (en) 2001-08-16
NZ520635A (en) 2004-05-28
KR100768331B1 (ko) 2007-10-18
JP5102925B2 (ja) 2012-12-19
NO20023769D0 (no) 2002-08-09
DE60129669T2 (de) 2008-05-21
CZ300326B6 (cs) 2009-04-22
CN1425017A (zh) 2003-06-18
DK1255759T3 (da) 2007-12-17

Similar Documents

Publication Publication Date Title
NZ334704A (en) Process for producing ecteinascidin compounds, intermediates and medicaments
EP2175021A3 (de) Verfahren zur Herstellung von Polymeren
IL148194A0 (en) A method of producing a compressed product
CA2397232A1 (en) Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
MY134189A (en) Process for preparing crystalline form i of cabergoline
IL151168A0 (en) Process for producing a pentacyclic compound as an intermediate for the production of ecteinascidin and phthalascidin compounds
AP9901698A0 (en) Novel process.
CY1105200T1 (el) Μεθοδος δια την παραγωγη διπepιδενης ii
IL156141A0 (en) A process for the preparation of taxan derivatives
MX9709812A (es) Nuevo derivado de fluoroetilcamptotecina soluble en agua y proceso para la produccion del mismo.
AU4498799A (en) Method of preparing 5- or 8-bromoisoquinoline derivatives
GB0108234D0 (en) Process for producing trunkamide A compounds
TW200510406A (en) Polymorphs of cabergoline
IL143079A (en) Process for the production of cyclene
GB2333294A (en) Cytokine production inhibitors
AU7851201A (en) Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
IS6058A (is) Aðferð til framleiðslu á 1,4,7,10-tetraasasýklódódekan
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
AU5925498A (en) Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
HU0001287D0 (en) New intermediate and process for its production
UA49267A (uk) Сировинна суміш для виготовлення ніздрюватого бетону
AU4132199A (en) Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method
AU2001273968A1 (en) Production of 2-ethyl-3-methyl-1,4-diazine
IT1313665B1 (it) Processo per la produzione di7alfa-alchil-17beta-idrossi-19-norpregn-5(10)
ES2190305A1 (es) Compuestos intermedios para la preparacion de mirtazapina y sus procedimientos de obtencion.